Advertisement
U.S. markets open in 6 hours 34 minutes
  • S&P Futures

    5,208.50
    -6.25 (-0.12%)
     
  • Dow Futures

    39,214.00
    -9.00 (-0.02%)
     
  • Nasdaq Futures

    18,188.50
    -43.00 (-0.24%)
     
  • Russell 2000 Futures

    2,046.90
    -2.90 (-0.14%)
     
  • Crude Oil

    82.49
    -0.23 (-0.28%)
     
  • Gold

    2,158.90
    -5.40 (-0.25%)
     
  • Silver

    25.13
    -0.14 (-0.53%)
     
  • EUR/USD

    1.0868
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2710
    -0.0019 (-0.15%)
     
  • USD/JPY

    150.3870
    +1.2890 (+0.86%)
     
  • Bitcoin USD

    64,887.26
    -3,610.86 (-5.27%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Company News for Aug 6, 2021

  • Shares of Regeneron Pharmaceuticals, Inc. REGN jumped 3.7% after the company reported second-quarter 2021 earnings of $25.80 per share, surpassing the Zacks Consensus Estimate of $19.55.

  • Hanesbrands Inc.’s HBI shares surged 6.3% after the company reported second-quarter 2021 earnings of 47 cents per share, beating the Zacks Consensus Estimate of 39 cents.

  • Shares of Kellogg Company K rose 0.8% after the company reported second-quarter 2021 earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.03.

  • YETI Holdings, Inc.’s YETI shares jumped 4.9% after the company reported second-quarter 2021 earnings of 68 cents per share, beating the Zacks Consensus Estimate of 57 cents.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
Hanesbrands Inc. (HBI) : Free Stock Analysis Report
 
Kellogg Company (K) : Free Stock Analysis Report
 
YETI Holdings, Inc. (YETI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement